Hassani Valiollah, Movaseghi Gholamreza, Safaeeyan Reza, Masghati Sahar, Ghorbani Yekta Batool, Farahmand Rad Reza
Pain Research Center, Iran University of Medical Sciences, Tehran, Iran.
Department of Anesthesiology, Hasheminezhad Hospital, Iran University of Medical Sciences, Tehran, Iran.
Anesth Pain Med. 2018 Aug 26;8(4):e79626. doi: 10.5812/aapm.79626. eCollection 2018 Aug.
Hypotension is a common problem in general anesthesia. Maintaining the mean arterial pressure by choosing a vasopressor with minimal complications is still discussed in various surgeries.
The aim of this study is comparison of ephedrine versus norepinephrine in treating anesthesia-induced hypotension in hypertensive patients in spinal surgery in a randomized double-blinded study.
This randomized, double-blinded study was approved by Iran University of Medical Sciences, operating room of medical center. Data collection was completed between Jan to Dec 2017. Inclusion criteria included age between 20 and 75 years, history of high blood pressure (a patient who has been treated for maximum 5 years with a anti hypertensive medication), and patients under general anesthesia in spinal surgery. The exclusion criteria were based on American Society of Anesthesiologists physical status of 3 or higher, history of arrhythmia, heart valve disease, cerebrovascular disease, kidney failure, beta-blocker use and diabetes, as well as intra operative massive blood loss. After initiation of anesthesia, when the pressure reaches less than 60, the patient entered the protocol and simultaneously administration of 5 mL/kg serum crystalloid and vasopressor. Patients were randomized to the ephedrine group (n = 28) who received 5 mg ephedrine intravenous (i.v.) or norepinephrine Group (n = 28) who received 10 µg (i.v.) bolus norepinephrine at anesthesia-induced hypotension. The administration of 5 mL/kg serum crystalloid and vasopressor was simultaneous. If the mean arterial pressure (MAP) had not reached 60 mmHg, the same dose should be repeated at a maximum of three or more times at five-minute intervals in the ephedrine group and at two minutes intervals in the norepinephrine group. All parameters were collected before and at the end of administration anesthesia drug and during episodes of hypotension. Hemodynamic variables, frequency of hypotension, and total number of vasopressors doses during anesthesia were recorded and analyzed.
The mean number of hypotension times, the number of vasopressors doses in the first hypotension, the total number of doses consumed during the anesthesia, and heart rate at the end of anesthesia were lower in the norepinephrine group (P) respectively. MAP, 5 minutes after the first episode of hypotension and MAP at the end of anesthesia were higher in norepinephrine group.
Norepinephrine is more effective than ephedrine in maintenance of MAP in hypertensive patients undergoing spinal surgery under general anesthesia.
低血压是全身麻醉中常见的问题。在各类手术中,如何选择并发症最少的血管升压药来维持平均动脉压仍存在争议。
本研究旨在通过一项随机双盲研究,比较麻黄碱与去甲肾上腺素治疗脊柱手术中高血压患者麻醉诱导性低血压的效果。
这项随机双盲研究经伊朗医科大学医学中心手术室批准。数据收集于2017年1月至12月完成。纳入标准包括年龄在20至75岁之间、有高血压病史(使用抗高血压药物治疗最长5年的患者)以及接受脊柱手术全身麻醉的患者。排除标准基于美国麻醉医师协会身体状况分级为3级或更高、有心律失常病史、心脏瓣膜病、脑血管疾病、肾衰竭、使用β受体阻滞剂和糖尿病,以及术中大量失血。麻醉开始后,当血压降至60以下时,患者进入研究方案,同时给予5 mL/kg晶体液和血管升压药。患者被随机分为麻黄碱组(n = 28),在麻醉诱导性低血压时静脉注射5 mg麻黄碱,或去甲肾上腺素组(n = 28),静脉注射10 μg去甲肾上腺素推注。同时给予5 mL/kg晶体液和血管升压药。如果平均动脉压(MAP)未达到60 mmHg,麻黄碱组应每隔5分钟重复相同剂量,最多重复三次或更多次,去甲肾上腺素组应每隔2分钟重复。在麻醉药物给药前、给药结束时以及低血压发作期间收集所有参数。记录并分析血流动力学变量、低血压发生频率以及麻醉期间血管升压药的总剂量。
去甲肾上腺素组的平均低血压次数、首次低血压时血管升压药的剂量数、麻醉期间消耗的总剂量数以及麻醉结束时的心率均较低(P)。去甲肾上腺素组在首次低血压发作后5分钟的MAP以及麻醉结束时的MAP较高。
在全身麻醉下接受脊柱手术的高血压患者中,去甲肾上腺素在维持MAP方面比麻黄碱更有效。